Provectus Life Sciences Private Limited
About Provectus Life Sciences Private Limited
Data last updated:
Provectus Life Sciences Private Limited is a private limited company based in Ghaziabad, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 January 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24233UP2015PTC067993.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Rajat Arora and Shashi Arora.
Its last annual general meeting (AGM) was held on 03 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kf – 9 Kavi Nagar, Ghaziabad, Uttar Pradesh, India – 201002.
As per the financials filed for FY 2025, the company reported a revenue of ₹35,865. For the same year it recorded a net profit of ₹20,970 (net margin 58.5%) and EBITDA of ₹20,970 (EBITDA margin 58.5%). Revenue has grown at a compounded annual rate (CAGR) of 87% over three years and 30% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Provectus Life Sciences Private Limited's registered office is in Ghaziabad, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressKf – 9 Kavi Nagar, Ghaziabad, Uttar Pradesh, India – 201002
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Provectus Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Provectus Life Sciences Private Limited
FY 2025 filings availableProvectus Life Sciences Private Limited reported revenue of ₹35,865 for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 30% over five years. EBITDA rose 286% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹20,970 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹20,970 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 58.5% | ||||
| Net Profit Margin | 58.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Provectus Life Sciences Private Limited, buy the company report.
Board of directors of Provectus Life Sciences Private Limited
Provectus Life Sciences has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajat Arora Also directs: Universal Developers Private Limited, Crown Realters and Amusements Private Limited, SP Hi-Fy Realtors Private Limited and 5 more | Director | 02 Jan 2015 | 11 Years 9 Months | Current |
| Shashi Arora Also directs: Universal Developers Private Limited, Crown Realters and Amusements Private Limited, SP Hi-Fy Realtors Private Limited and 5 more | Director | 20 Mar 2025 | 1 Years 7 Months | Current |
| Dinesh Arora Also directs: Universal Developers Private Limited, Crown Realters and Amusements Private Limited, SP Hi-Fy Realtors Private Limited and 5 more | Director | 20 Mar 2025 | 1 Years 7 Months | Current |
Peer comparison
Provectus Life Sciences Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Preventive Healthcare Services), with the same principal business activity (hospital activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shivam Lifeline Private Limited | ₹35,964 (FY 2024) | -51.0% | Bengaluru, Karnataka, India | |||
| Provectus Life Sciences Private Limitedthis company | ₹35,865 (FY 2025) | ₹20,970 | 58.5% | Ghaziabad, Uttar Pradesh, India | ||
| Lasertech Eye Centre Private Limited | ₹35,712 (FY 2025) | 60.0% | New Delhi, Delhi, India | |||
| Sahaya Holistic Integrative Hospital Private Limited | ₹35,250 (FY 2024) | Bangalore, Karnataka, India |
To see the full peer comparison of Provectus Life Sciences Private Limited, buy the company report.
Auditor
Provectus Life Sciences Private Limited is audited by R K GOVIL & CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R K GOVIL & CO | FY 2017 | 000748C |
Shareholding
The shareholding of Provectus Life Sciences Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Provectus Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Provectus Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Provectus Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Provectus Life Sciences Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Provectus Life Sciences Private Limited has 6 board changes on record since 2015: 3 appointments and 3 cessations. The latest: Dinesh Arora ceased to be Additional Director on 02 Sep 2025.
Frequently asked questions
Provectus Life Sciences is an active private limited company based in Ghaziabad, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 January 2015 (11+ years old) and is registered under CIN U24233UP2015PTC067993.
Provectus Life Sciences has 3 current directors:
- Rajat Arora - Director
- Shashi Arora - Director
- Dinesh Arora - Director
The latest financial statements of Provectus Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 03 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Provectus Life Sciences is U24233UP2015PTC067993. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Provectus Life Sciences was incorporated on 02 January 2015, making it 11+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Provectus Life Sciences by revenue are Shivam Lifeline Private Limited, Lasertech Eye Centre Private Limited, Sahaya Holistic Integrative Hospital Private Limited, all in the Healthcare industry (Preventive Healthcare Services), with the same principal business activity (hospital activities).
Dinesh Arora ceased to be Additional Director on 02 Sep 2025. Shashi Arora ceased to be Additional Director on 02 Sep 2025. Prem Narain Arora ceased to be Director on 21 Mar 2025. Provectus Life Sciences has 6 board changes on record in total.
The registered office of Provectus Life Sciences is at Kf – 9 Kavi Nagar, Ghaziabad, Uttar Pradesh, India – 201002.
Provectus Life Sciences operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Provectus Life Sciences is compliant as of 24 August 2026. The company is actively filing with the Registrar of Companies.
Provectus Life Sciences can be reached at its registered office: Kf – 9 Kavi Nagar, Ghaziabad, Uttar Pradesh, India – 201002.